Replimune REPL
$19.07 −$0.16 (-0.83%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $19.09 +0.10%
Open$18.84
Prev close$19.23
Day range$18.69 – $19.50
Volume1.96M
Market cap$1.81B
P/E (TTM)–
Dividend yield–
REPL Stock News
Headlines matching Replimune or the REPL ticker, most recent first.
- Sri Trang Gloves: REPL-General Announcement-Reporting Share Repurchase form for Financial Management Purposes No.2 (Revised Date)
- BMO Capital Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $20
- Wedbush Upgrades Replimune(REPL.US) to Buy Rating, Raises Target Price to $19 Positive
- Piper Sandler Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $14
- BMO Capital Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $20 Positive
- Leerink Partners Initiates Replimune(REPL.US) With Buy Rating, Announces Target Price $17
- Frasers Property: REPL-General Announcement-Issue of S$150 Million Fixed Rate Notes Due 2036 By Frasers Property Treasury Pte. Ltd.
- J.P. Morgan Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $21 Positive
- Jefferies Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $24 Positive
- Wedbush Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $19
- J.P. Morgan Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $20 Positive
- Cantor Fitzgerald Upgrades Replimune(REPL.US) to Buy Rating Positive
- Wedbush Upgrades Replimune(REPL.US) to Buy Rating, Raises Target Price to $12 Positive
- BMO Capital Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $16
- Wedbush Downgrades Replimune(REPL.US) to Hold Rating, Cuts Target Price to $9 Negative
No comments yet — be the first to weigh in on REPL.
Sign in to join the discussion.